Muscará M N, Wallace J L
Department of Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada T2N 4N1.
Am J Physiol. 1999 Jun;276(6):G1313-6. doi: 10.1152/ajpgi.1999.276.6.G1313.
Nitric oxide is a crucial mediator of gastrointestinal mucosal defense, but, paradoxically, it also contributes to mucosal injury in several situations. Inhibitors of nitric oxide synthesis and compounds that release nitric oxide have been useful pharmacological tools for evaluating the role of nitric oxide in gastrointestinal physiology and pathophysiology. Newer inhibitors with selectivity for one of the isoforms of nitric oxide synthase are even more powerful tools and may have utility as therapeutic agents. Also, agents that can scavenge nitric oxide or peroxynitrite are promising as drugs to prevent nitric oxide-associated tissue injury. Compounds that release nitric oxide in small amounts over a prolonged period of time may also be very useful for prevention of gastrointestinal injury associated with shock and with the use of drugs that have ulcerogenic effects. Indeed, the coupling of a nitric oxide-releasing moiety to nonsteroidal anti-inflammatory drugs has proven to be a valid means of substantially reducing the gastrointestinal toxicity of these drugs without decreasing their efficacy.
一氧化氮是胃肠道黏膜防御的关键介质,但矛盾的是,在某些情况下它也会导致黏膜损伤。一氧化氮合成抑制剂和释放一氧化氮的化合物一直是评估一氧化氮在胃肠道生理和病理生理中作用的有用药理学工具。对一氧化氮合酶同工型之一具有选择性的新型抑制剂是更强大的工具,可能具有治疗剂的用途。此外,能够清除一氧化氮或过氧亚硝酸盐的药物有望作为预防一氧化氮相关组织损伤的药物。长时间少量释放一氧化氮的化合物对于预防与休克以及使用具有致溃疡作用的药物相关的胃肠道损伤也可能非常有用。事实上,将释放一氧化氮的部分与非甾体抗炎药偶联已被证明是在不降低其疗效的情况下大幅降低这些药物胃肠道毒性的有效方法。